Clinical and treatment characteristics determining therapeutic outcome in patients undergoing autologous non-cultured outer root sheath hair follicle cell suspension for treatment of stable vitiligo

被引:36
|
作者
Vinay, K. [1 ]
Dogra, S. [1 ]
Parsad, D. [1 ]
Kanwar, A. J. [1 ]
Kumar, R. [1 ]
Minz, R. W. [2 ]
Saikia, U. N. [3 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Dermatol Venereol & Leprol, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Immunopathol, Chandigarh 160012, India
[3] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh 160012, India
关键词
TRANSPLANTATION;
D O I
10.1111/jdv.12426
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundAutologous non-cultured outer root sheath hair follicle cell suspension (NCORSHFS) is a recently described novel cellular graft technique for the treatment of stable vitiligo. There is lack of data about various factors determining the repigmentation rate in vitiligo patients undergoing this novel surgical therapy. ObjectiveTo study the clinical characteristics and treatment variables determining therapeutic outcome in patients of stable vitiligo undergoing NCORSHFS. MethodsNon-cultured outer root sheath hair follicle cell suspension was prepared from anagen hairs extracted from the occipital area. The number of melanocytes and hair follicle stem cells (HFSC) in the suspension was quantified by staining with anti-HMB45 and anti-CD200 antibody, respectively. In all patients, a 2mm punch skin biopsy was taken from one of the vitiligo patch to be treated prior to surgery for assessment of histomorphological features. Post surgery patients were followed up at regular intervals for 24weeks. ResultsThirty patients (21 females, 9 males) with a clinical diagnosis of stable vitiligo, with a total of 60 target lesions were included in this study. The mean age of the study population was 21.105.64years. The number of melanocytes (P=0.04) and HFSC (P=0.01) transplanted were significantly higher among patients achieving optimum repigmentation (>75% repigmentation). There was a strong correlation between repigmentation at 24week and number of melanocytes and HFSC transplanted. Number of HFSC transplanted and absence of dermal inflammation were significant predictors of achieving optimum repigmentation. ConclusionThe number of melanocytes and HFSC transplanted and absence of dermal inflammation were important determents of optimal repigmentation in patients undergoing NCORSHFS for treatment of stable vitiligo. Hence, refining the technique of NCORSHFS on the basis of these factors would help in achieving better surgical outcomes.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 29 条
  • [1] Clinical and treatment characteristics determining therapeutic outcome in patients undergoing autologous noncultured outer root sheath hair follicle cell suspension for treatment of stable vitiligo
    Vinay, K.
    Dogra, S.
    Parsad, D.
    Kanwar, A.
    Minz, R.
    Saikia, U.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 68 - 69
  • [2] Treatment of stable vitiligo using cultured and non-cultured autologous melanocytes from hair follicle outer root sheath cell suspension
    Gad, Heba
    El Hawary, Marwa
    Swelim, Hamdy
    Mahmoud, Yomna
    Shawky, Shereen
    JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY, 2020, 17 (02): : 104 - 112
  • [3] Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study
    Singh, C.
    Parsad, D.
    Kanwar, A. J.
    Dogra, S.
    Kumar, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (02) : 287 - 293
  • [4] Dermatoscopic assessment of treatment response in patients undergoing autologous non-cultured epidermal cell suspension for the treatment of stable vitiligo: A prospective study
    Dev, Anubha
    Vinay, Keshavamurthy
    Bishnoi, Anuradha
    Kumaran, Muthu Sendhil
    Dogra, Sunil
    Parsad, Davinder
    DERMATOLOGIC THERAPY, 2021, 34 (05)
  • [5] The clinical efficacy of treatment using the autologous non-cultured epidermal cell suspension technique for stable vitiligo in 41 patients
    Liu, Bin
    Chen, Hui-Heng
    Liu, Zhong-Hai
    Liang, Jing-Feng
    Xue, Ru-Jun
    Chen, Ping-Jiao
    Li, Chang-Xing
    Liang, Xiao-Dong
    Deng, Jie
    Ye, Rui-Xian
    Zhang, Xi-Bao
    Liang, Jing-Yao
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (01) : 90 - 94
  • [6] Noncultured extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo
    Mohanty, S.
    Kumar, A.
    Dhawan, J.
    Sreenivas, V.
    Gupta, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (06) : 1241 - 1246
  • [7] Autologous non-cultured epidermal cell suspension combined with platelet rich fibrin for the treatment of stable vitiligo: A case series
    Nareswari, Adniana
    Zulfikar, Dendy
    Julianto, Indah
    Widhiati, Suci
    DERMATOLOGY REPORTS, 2019, 11 : 11 - 13
  • [8] Evaluation of clinical efficacy and laboratory indicators of non-cultured epidermal cell suspension and hair follicle cell suspension in surgical management of stable vitiligo: A randomized comparative trial
    Challa, Apoorva
    Chauhan, Suman
    Pangti, Rashi
    Arava, Sudheer Kumar
    Prajapati, Sapna
    Pandey, Anjali
    Gupta, Somesh
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (12) : 6958 - 6964
  • [9] Electrofulguration-assisted dermabrasion is comparable to manual dermabrasion in patients undergoing autologous non-cultured epidermal cell suspension for treatment of stable vitiligo: A randomized controlled trial
    Dev, Anubha
    Vinay, Keshavamurthy
    Kumaran, Muthu Sendhil
    Bishnoi, Anuradha
    Srivastava, Niharika
    Dogra, Sunil
    Parsad, Davinder
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (04) : 1574 - 1581
  • [10] Comparison of efficacy of cold trypsinization versus warm trypsinization in preparation of autologous non-cultured epidermal cell suspension for treatment of stable vitiligo
    Awasti, S.
    Vinay, K.
    Thakur, V.
    Kumar, R.
    Holla, A. P.
    Sahni, K.
    Parsad, D.
    Kanwar, A. J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (06) : E237 - E239